Hyperalgesia in the Psychological Stress-Induced Fibromyalgia Model Shows Sexual Dimorphism Mediated by LPA1 and LPA3
Cells · 2025
DOI: 10.3390/cells14131022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Hiroshi Ueda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutic Innovation, Nagasaki University Institute of Biomedical Sciences, Nagasaki 852-8521, Japan. Hauptthemen laut MEDLINE: Hyperalgesia, Receptors, Lysophosphatidic Acid, Fibromyalgia, Sex Characteristics. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, National Science and Technology Council.
Abstract (Originalsprache)
Since the initial report indicating that LPA1 signaling plays a key role in initiating nerve injury-induced neuropathic pain (NeuP), subsequent studies using knockout mice and LPA1/3 antagonists have demonstrated that LPA1 and LPA3 signaling impact NeuP and fibromyalgia (FM) models. In the present study, we identified hyperalgesia sexual dimorphism involving LPA1/3 signaling in the intermittent psychological stress induced-related FM-like model called intermittent psychological stress (IPS)-induced generalized pain (IPGP) model where the hyperalgesia in IPGP mice was abolished in LPA1- and LPA3-knock-out mice. Pharmacological intervention by intraperitoneal (i.p.) treatments with the LPA1/3 antagonist Ki16425 consistently prevented hyperalgesia. However, intracerebroventricular treatments with Ki16425 abolished hyperalgesia in male, but not female, mice. Notably, intrathecal treatments of Ki16425 did not prevent hyperalgesia. Further studies revealed that splenocytes derived from female IPGP mice could initiate hyperalgesia via adoptive transfer in naïve mice, and this effect was abolished when donor mice were pre-treated with Ki16425 (i.p.). Thus, these studies identify male-specific LPA1/3-mediated mechanisms in the brain underlying IPGP, as well as distinct LPA-LPA1/3-mediated peripheral immune mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutic Innovation, Nagasaki University Institute of Biomedical Sciences, Nagasaki 852-8521, Japan.
- Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- Laboratory for the Study of Pain, Research Institute for Production Development, Kyoto 606-0805, Japan.
- Graduate Institute of Pharmacology, National Defense Medical Center, Nei-hu, Taipei 114201, Taiwan.
- Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
- Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
ORCID-Profile: Hiroyuki Neyama, Jerold Chun
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- National Science and Technology Council
- NSTC (R.O.C. Taiwan)
Zitieren
APA
Ueda, H., Neyama, H., Dozono, N., Aoki, J., & Chun, J. (2025). Hyperalgesia in the Psychological Stress-Induced Fibromyalgia Model Shows Sexual Dimorphism Mediated by LPA1 and LPA3. Cells. https://doi.org/10.3390/cells14131022
Vancouver
Ueda H, Neyama H, Dozono N, Aoki J, Chun J. Hyperalgesia in the Psychological Stress-Induced Fibromyalgia Model Shows Sexual Dimorphism Mediated by LPA1 and LPA3. Cells. 2025. doi:10.3390/cells14131022
BibTeX
@article{Ueda2025,
author = {Ueda, Hiroshi and Neyama, Hiroyuki and Dozono, Naoki and Aoki, Junken and Chun, Jerold},
title = {Hyperalgesia in the Psychological Stress-Induced Fibromyalgia Model Shows Sexual Dimorphism Mediated by LPA1 and LPA3},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14131022}
}
EUVIMED